A- A A+

For Patients & Visitors

Find a Doctor

Find a Doctor

Dr Angela Pang

Photo of Dr Angela Pang
MBBS (S'pore), Grad Dip (GRM), MRCP (UK), M Med (Internal Med)
Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore
Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore
Sub Specialty:
Geriatric Oncology, Haematology-Oncology, Medical Oncology
Medical and Surgical Conditions:
Bone Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (Stomach Cancer), Gastrointestinal Stromal Tumour (GIST), Musculoskeletal Cancer, Sarcoma, Soft Tissue Cancer
Special Interest:
Bone and Soft Tissue Sarcomas
Geriatric Oncology
Gastrointestinal Cancers
National University Hospital
National University Cancer Institute, Singapore
National University Health System
Dr Angela Pang is currently a Consultant in the Department of Haematology-Oncology of National University Cancer Institute, Singapore (NCIS). She obtained her undergraduate degree from the School of Medicine, National University of Singapore (NUS). Thereafter, she obtained her postgraduate qualifications - Masters in Medicine (Internal Medicine) from NUS, and her Membership of the Royal College of Physicians (UK). Subsequently, she went on to complete her advanced specialist training in Medical Oncology in the National University Hospital (NUH), Singapore and was awarded the NCIS research scholarship for her Sarcoma research fellowship with Professor Robert G Maki in the Tisch Cancer Institute, Mount Sinai Hospital, New York. 

With a specific interest in the optimisation of care in elderly cancer patients, Dr Pang further pursued a Graduate Diploma in Geriatric Medicine with the Yong Loo Lin School of Medicine (YLLSOM). In order to integrate her expertise in both geriatrics and oncology, she also trained in Geriatric Oncology with Dr Beatriz Korc and Dr Stuart Lichtman in the Memorial Sloan Kettering Cancer Center, New York. 

As Dr Pang’s main clinical interests are in bone/soft tissue sarcomas, gastrointestinal cancers and geriatric oncology, she is the co-lead for the Musculoskeletal oncology service in NCIS, and has also initiated several pilot projects for a multi-disciplinary geriatric oncology service in NCIS. She is also a principal investigator for several international multi-centre cancer clinical trials and also a recipient of several grants. Her research work has been published in peer reviewed journals including the Journal of Clinical Oncology (JCO), Journal of American Society of Medicine (JAMA) Oncology, British Medical Journal (BMJ) GUT, Oncotarget and others. 

Dr Pang is also actively involved in both undergraduate and post graduate education at the YLLSOM and NUH respectively. She has been awarded for teaching excellence and is currently appointed as Assistant Professor for Faculty of Medicine, YLLSOM and serves as core faculty of the undergraduate education (Medical Oncology) and Senior Residency (Medical Oncology) of NUH.

Awards and Honours

NUHS Inter Professional Teaching Award 2014
NCIS Postgraduate Teaching Excellence Award 2015
NCIS Research Fellow Scholarship 2015
Clinical Investigator Program Grant, NCIS Centre Grant Call 2016
Singapore Cancer Society Research Grant 2016

Professional Memberships

American Society of Clinical Oncology (ASCO)
European Society of Clinical Oncology (ESMO)
Connective Tissue Oncology Society (CTOS)
Society of Geriatric Oncology (SIOG)

Research and Publications

  1. Editor's quiz: GI snapshot; Gut, Volume 58; Issue 6 - A case of persistent vomiting. A Pang, P L Chia, B Ang, S A Buhari, B Y S Chuah. GUT 2009;58:750; doi:10.1136/gut.2008.167643.
  2. A case of sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma.Pang A, Tan KB, Aw D, Hsieh WS, Goh BC, Lee SC. Cutaneous and Ocular Toxicology. 2012 Mar;31(1):64-6. doi:10.3109/15569527.2011. 602034. Epub 2011 Aug 26.
  3. Cancer physicians' attitude towards treatment of the elderly cancer patient in a developed Asian country. Angela Pang, Shirlynn Ho and Soo-Chin Lee BMC Geriatr. 2013 Apr 16;13:35. doi: 10.1186/1471-2318-13-35. 
  4. Hepatitis B virus reactivation risk varies with different chemotherapy regimes commonly used in solid tumours. Ling WH, Soe PP, Pang AS, Lee SC. Br J Cancer. 2013 May 28;108(10):1931-5. doi: 10.1038/bjc.2013.225. Epub 2013 May 7.
  5. Lymphadenopathy and airway obstruction. Li A, Khoo KL, Tan CL, Pang A, Lee P. Am J Respir Crit Care Med. 2015 Jan 1;191(1):e1-3. doi: 10.1164/rccm.201409 1622IM.
  6. Contemporary Therapy for Advanced Soft-Tissue Sarcomas in Adults: A Review. Angela Pang, Mariana Carbini, Robert G. Maki JAMA Oncol. 2016;2(7):941-947.
  7. Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer . Andrea L.A. Wong, Raghav Sundar, Ting-Ting Wang, Thian-C Ng, Bo Zhang, Sing-Huang Tan, Thomas I.P. Soh, Angela S.L. Pang, Chee-Seng Tan, Samuel G.W. Ow, Lingzhi Wang, Jannet Mogro, Jingshan Ho, Anand D. Jeyasekharan, Yiqing Huang, Choon-Hua Thng, Ching-Wan Chan, Mikael Hartman, Philip Iau, Shaik A. Buhari, Boon-Cher Goh, Soo-Chin Lee Oncotarget. 2016 Sep 27; 7(39): 64089–6409.


Appt Tel:
+65 6777 4413